بدائل البحث:
largest decrease » largest decreases (توسيع البحث), larger decrease (توسيع البحث), marked decrease (توسيع البحث)
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
c largest » _ largest (توسيع البحث), c large (توسيع البحث)
16 cases » 19 cases (توسيع البحث), _ cases (توسيع البحث), 3 cases (توسيع البحث)
a large » _ large (توسيع البحث)
c cases » ic cases (توسيع البحث), _ cases (توسيع البحث), 3 cases (توسيع البحث)
largest decrease » largest decreases (توسيع البحث), larger decrease (توسيع البحث), marked decrease (توسيع البحث)
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
c largest » _ largest (توسيع البحث), c large (توسيع البحث)
16 cases » 19 cases (توسيع البحث), _ cases (توسيع البحث), 3 cases (توسيع البحث)
a large » _ large (توسيع البحث)
c cases » ic cases (توسيع البحث), _ cases (توسيع البحث), 3 cases (توسيع البحث)
-
121
Norm ISWSVR: A Data Integration and Normalization Approach for Large-Scale Metabolomics
منشور في 2022"…More importantly, Norm ISWSVR also allows a low frequency of QCs, which could significantly decrease the burden of a large-scale experiment. …"
-
122
The COVID-19 pandemic affects seasonality with increasing cases of new-onset type 1 diabetes in children from the worldwide SWEET registry
منشور في 2022"…<p> </p> <p><strong>Aims: </strong>To analyze whether the COVID-19 pandemic increased the number of cases or impacted seasonality of new-onset type 1 diabetes (T1D) in large pediatric diabetes centers globally. …"
-
123
-
124
-
125
Decreased MBP levels in the brain in <i>Large</i><sup><i>myd/myd</i></sup> mice.
منشور في 2020"…<p><b>A,</b> Brain sections of eight-week-old control and <i>Large</i><sup><i>myd/myd</i></sup> mice at the level of the corpus callosum were obtained for immunostaining for MBP (Scale bars: 200 μm). …"
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
Characteristics of 16 included studies.
منشور في 2023"…Negative anti-HBs (crude odds ratio [OR] 5.05; 95% CI [2.83, 9.00]; <i>p</i> < 0.001; I<sup>2</sup> = 0%), ABO blood type-incompatible transplantation (crude OR 2.62; 95% CI [1.05, 6.04]; <i>p</i> = 0.040; I<sup>2</sup> = 0%), history of acute rejection (crude OR 2.37; 95% CI [1.13, 4.97]; <i>p</i> = 0.022; I<sup>2</sup> = 0%), ATG use (crude OR 3.19; 95% CI [1.48, 6.87]; <i>p</i> = 0.003; I<sup>2</sup> = 0%), and rituximab use (crude OR 3.16; 95% CI [1.24, 8.06]; <i>p</i> = 0.016; I<sup>2</sup> = 0%) increased the risk of reactivation. …"
-
134
-
135
-
136
-
137
-
138
-
139
-
140